Literature DB >> 31419390

Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis.

Robert P Dickson1,2, Gary B Huffnagle1,3, Kevin R Flaherty1, Eric S White1, Fernando J Martinez4, John R Erb-Downward1, Bethany B Moore1,3, David N O'Dwyer1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31419390      PMCID： PMC6909839          DOI： 10.1164/rccm.201903-0680LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Authors:  David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

3.  The potential impact of azithromycin in idiopathic pulmonary fibrosis.

Authors:  Claudio Macaluso; Joaquín Maritano Furcada; Omamah Alzaher; Ritesh Chaube; Felix Chua; Athol U Wells; Toby M Maher; Peter M George; Elizabeth A Renzoni; Philip L Molyneaux
Journal:  Eur Respir J       Date:  2019-02-14       Impact factor: 16.671

4.  Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.

Authors:  Lisa A Carmody; Jiangchao Zhao; Patrick D Schloss; Joseph F Petrosino; Susan Murray; Vincent B Young; Jun Z Li; John J LiPuma
Journal:  Ann Am Thorac Soc       Date:  2013-06

5.  Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.

Authors:  Georgios D Kitsios; Mauricio Rojas; Daniel J Kass; Adam Fitch; John C Sembrat; Shulin Qin; Kristen L Veraldi; Kevin F Gibson; Kathleen Lindell; Joseph M Pilewski; Barbara Methe; Kelvin Li; John McDyer; Bryan J McVerry; Alison Morris
Journal:  Thorax       Date:  2017-08-11       Impact factor: 9.139

6.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Authors:  Ganesh Raghu; Kevin J Anstrom; Talmadge E King; Joseph A Lasky; Fernando J Martinez
Journal:  N Engl J Med       Date:  2012-05-20       Impact factor: 91.245

7.  Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Stephen J Gurczynski; Meng Xia; Carol Wilke; Nicole R Falkowski; Katy C Norman; Kelly B Arnold; Gary B Huffnagle; Margaret L Salisbury; MeiLan K Han; Kevin R Flaherty; Eric S White; Fernando J Martinez; John R Erb-Downward; Susan Murray; Bethany B Moore; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

8.  Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

Authors:  Philip L Molyneaux; Saffron A G Willis-Owen; Michael J Cox; Phillip James; Steven Cowman; Michael Loebinger; Andrew Blanchard; Lindsay M Edwards; Carmel Stock; Cécile Daccord; Elisabetta A Renzoni; Athol U Wells; Miriam F Moffatt; William O C Cookson; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

9.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Authors:  Phillip L Molyneaux; Michael J Cox; Saffron A G Willis-Owen; Patrick Mallia; Kirsty E Russell; Anne-Marie Russell; Elissa Murphy; Sebastian L Johnston; David A Schwartz; Athol U Wells; William O C Cookson; Toby M Maher; Miriam F Moffatt
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 30.528

10.  The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.

Authors:  Max A Seibold; Russell W Smith; Cydney Urbanek; Steve D Groshong; Gregory P Cosgrove; Kevin K Brown; Marvin I Schwarz; David A Schwartz; Susan D Reynolds
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240
  10 in total
  10 in total

Review 1.  Update in Interstitial Lung Disease 2019.

Authors:  Sydney B Montesi; Jolene H Fisher; Fernando J Martinez; Moisés Selman; Annie Pardo; Kerri A Johannson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

Review 2.  The evolving role of the lung microbiome in pulmonary fibrosis.

Authors:  Jay H Lipinski; Bethany B Moore; David N O'Dwyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 5.464

3.  Cage Environment Regulates Gut Microbiota Independent of Toll-Like Receptors.

Authors:  J H Lipinski; X Zhou; S J Gurczynski; J R Erb-Downward; R P Dickson; G B Huffnagle; B B Moore; D N O'Dwyer
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

4.  Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.

Authors:  Eleanor Valenzi; Haopu Yang; John C Sembrat; Libing Yang; Spencer Winters; Rachel Nettles; Daniel J Kass; Shulin Qin; Xiaohong Wang; Michael M Myerburg; Barbara Methé; Adam Fitch; Jonathan K Alder; Panayiotis V Benos; Bryan J McVerry; Mauricio Rojas; Alison Morris; Georgios D Kitsios
Journal:  Thorax       Date:  2020-12-02       Impact factor: 9.139

5.  Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent.

Authors:  Rachele Invernizzi; Joseph Barnett; Bhavin Rawal; Arjun Nair; Poonam Ghai; Shaun Kingston; Felix Chua; Zhe Wu; Athol U Wells; Elizabeth R Renzoni; Andrew G Nicholson; Alexandra Rice; Clare M Lloyd; Adam J Byrne; Toby M Maher; Anand Devaraj; Philip L Molyneaux
Journal:  Eur Respir J       Date:  2020-04-03       Impact factor: 16.671

Review 6.  Microbiome dysbiosis in lung cancer: from composition to therapy.

Authors:  Ning-Ning Liu; Qiang Ma; Yang Ge; Cheng-Xiang Yi; Lu-Qi Wei; Jing-Cong Tan; Qiao Chu; Jing-Quan Li; Peng Zhang; Hui Wang
Journal:  NPJ Precis Oncol       Date:  2020-12-10

Review 7.  The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Paolo Spagnolo; Philip L Molyneaux; Nicol Bernardinello; Elisabetta Cocconcelli; Davide Biondini; Federico Fracasso; Mariaenrica Tiné; Marina Saetta; Toby M Maher; Elisabetta Balestro
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923

Review 8.  Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.

Authors:  Josep Mercader-Barceló; Joan Truyols-Vives; Carlos Río; Nora López-Safont; Ernest Sala-Llinàs; Alice Chaplin
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

9.  The Lung Microbiome in Health, Hypersensitivity Pneumonitis, and Idiopathic Pulmonary Fibrosis: A Heavy Bacterial Burden to Bear.

Authors:  David N O'Dwyer; Stavros Garantziotis
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

10.  Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.

Authors:  Corina N D'Alessandro-Gabazza; Taro Yasuma; Tetsu Kobayashi; Masaaki Toda; Ahmed M Abdel-Hamid; Hajime Fujimoto; Osamu Hataji; Hiroki Nakahara; Atsuro Takeshita; Kota Nishihama; Tomohito Okano; Haruko Saiki; Yuko Okano; Atsushi Tomaru; Valeria Fridman D'Alessandro; Miyako Shiraishi; Akira Mizoguchi; Ryoichi Ono; Junpei Ohtsuka; Masayuki Fukumura; Tetsuya Nosaka; Xuenan Mi; Diwakar Shukla; Kensuke Kataoka; Yasuhiro Kondoh; Masaki Hirose; Toru Arai; Yoshikazu Inoue; Yutaka Yano; Roderick I Mackie; Isaac Cann; Esteban C Gabazza
Journal:  Nat Commun       Date:  2022-03-23       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.